Zhongying Fund

Public record indicates the firm pursues both growth equity and general venture capital. Growth-stage investments typically involve minority or control positions in expansion-phase companies, while the venture mandate suggests exposure to earlier-stage technology or consumer enterprises. Precise allocation between stages is not publicly disclosed.

Zhongying Fund operates as a domestic renminbi-denominated manager, based on its Beijing headquarters and Chinese limited partner base. There is no evidence of an offshore USD parallel fund structure. This onshore-only posture differentiates it from Chinese GPs that maintain dual-currency platforms.

Named principals and the investment committee structure are not publicly available. As with many Chinese private equity firms registered with the Asset Management Association of China, key persons are typically identified in AMAC filings, though these are not accessible in standard commercial databases for this specific manager.

The firm does not publish a sector- or industry-specific mandate. General growth and venture strategies in China commonly span technology, consumer, healthcare, and advanced manufacturing. Without portfolio disclosures or a stated investment thesis, specific sector concentrations cannot be confirmed.

Deal origination likely relies on domestic networks typical of Beijing-based renminbi managers — including relationships with entrepreneurs, state-owned enterprise spinouts, local government guidance funds, and intermediary referrals. No proprietary sourcing model or institutional partnerships are publicly documented.